standard-title
Alzheimer’s Disease
Latest News Regarding Alzheimer’s Disease and Your Health
Loading…
Latest Alzheimer’s News MONDAY, Dec. 17, 2018 (HealthDay News) — Lots of Americans will unwrap a scarf or sweater this holiday season. But a growing number will receive a gift that’s potentially life-changing: an at-home genetic testing kit. Home DNA testing yields clues to ancestry and, potentially, genetic risk for medical conditions. But there are a number of things you need to know before you use one of these kits, the Alzheimer’s Foundation of America says. “Genetic testing kits are a popular gift, but the test results can have implications that last long after the holidays,” Lori Frank said in a foundation news release. She’s on the foundation’s medical, scientific and memory screening advisory board. “As with any health decision, consumers should have the right information before deciding to take a genetic test,” Frank said. Because genetic testing has potentially positive and negative impacts, the foundation offers some tips: Be informed. “Some people find the results upsetting and are concerned about the emotional impact to relatives with similar genetic risk, while others feel empowered to proactively take better care of their own health. It’s important to consider all impacts beforehand,” said Dr. J. Wesson Ashford, chair of the medical, scientific […]
Recent research reveals that leaky capillaries in the brain could have a role in the development of Alzheimer’s disease. Changes in blood vessel permeability offer new clues about the onset of dementia. Dementia, the main type of which is Alzheimer’s disease, affects about 50 million people worldwide. According to the Alzheimer’s Association, over 5 million people in the United States are living with Alzheimer’s. This number is expected to reach 14 million by 2050. For this reason, it is becoming more and more important to diagnose these health conditions earlier, and to locate new targets for drugs to slow down or prevent the condition. The Food and Drug Administration (FDA) have approved some drugs that help with the symptoms of Alzheimer’s disease, but none of them treat the underlying cause. A new study conducted at the University of Southern California (USC) in Los Angeles could pave the way for new, more effective treatments. The findings now appear in the journal Nature Medicine. Leaky capillaries in the brain Previous studies indicated that two toxic proteins, amyloid and tau, may be “the trigger and bullet” in the development of Alzheimer’s. Findings showed that soluble forms of amyloid and tau work together to […]
As interest in gut bacteria peaks, they are implicated in yet another condition. Researchers recently identified stark differences in levels of specific gut bacteria in people with dementia. A new study links changes in gut bacteria to dementia. Our bodies swarm with microscopic visitors. On our skin, in our mouths, deep in our lungs, and, of course, nestled in our digestive systems. The bacteria in the gut have long been known to assist the digestive process, but in recent years, it has become clear that they are involved in much, much more. With bacteria now implicated in conditions as diverse as diabetes and schizophrenia, we truly are in the age of the microbiome. Recently, researchers in Japan investigated whether gut bacteria might, one day, help in the diagnosis and even treatment of dementia. Dr. Naoki Saji, from the Center for Comprehensive Care and Research on Memory Disorders at the National Center for Geriatrics and Gerontology in Obu, Japan, led the team of scientists. The researchers will present their findings at the American Stroke Association’s International Stroke Conference 2019 in Honolulu, HI. Examining feces The researchers recruited 128 participants from their memory clinic. The average age was 74.2, and 59 percent […]
Biogen, a multinational biotechnology company, and Eisai, a Japanese pharmaceutical company, are planning to file for Food and Drug Administration (FDA) approval for an Alzheimer’s drug that had mixed results in clinical trials. Can this controversial medication offer fresh hope to millions of people worldwide? A multinational biotech company will push for the regulation of a new Alzheimer’s drug that has met with some controversy. Across the world, around 50 million people live with dementia, the most common form of which is Alzheimer’s disease. Researchers are continually developing and testing new drugs to try and slow down, reverse, or at least improve the symptoms of this currently incurable condition. Yet many new drugs that scientists develop never make it beyond the clinical trial stage, as they either cause too many side effects or prove much less effective than their creators had hoped. And then there are some drugs that bring about mixed results when tested in clinical trials. One such drug is aducanumab, which was developed by scientists affiliated with Biogen, a multinational biotechnology company headquartered in Cambridge, MA. Aducanumab is a monoclonal antibody that is supposed to prevent or slow down neurodegeneration by removing toxic beta-amyloid plaques from the […]
Latest Alzheimer’s News FRIDAY, Dec. 6, 2019 (HealthDay News) — New study results about an experimental drug its maker claims can slow mental decline in Alzheimer’s disease patients were released Thursday. Studies on aducanumab were halted earlier this year because the drug didn’t appear to be effective. But the new results suggest it’s effective at a high dose, the Associated Press reported. The findings were presented at an Alzheimer’s conference in San Diego. However, some experts say that changes during the study and unusual analyses make the results difficult to interpret and the risks and benefits of the drug unclear, the AP reported. “I don’t see how you can conclude anything other than that another trial needs to be done,” said Dr. David Knopman of the Mayo Clinic, who is a member of an FDA panel likely to review the drug. He’s not likely to participate in such a review because he was involved in one of the studies, the AP reported. Aducanumab — being developed by U.S. company Biogen and Japanese company Eisai — is designed to clear harmful plaques, or protein clumps, from the brain. Copyright © 2019 HealthDay. All rights reserved. SLIDESHOW Dementia, Alzheimer’s Disease, and Aging […]
Latest Alzheimer’s News FRIDAY, Feb. 21, 2020 (HealthDay News) — A proposed project to map the genes of 1 million people in New York living with or at-risk for Alzheimer’s disease was announced Friday by Gov. Andrew Cuomo. He said the five years of data collected by the Curing Alzheimer’s Health Consortium initiative at the State University of New York would help researchers working to slow the progression of Alzheimer’s, the Associated Press reported. The state will seek proposals for private providers to work with SUNY, other hospitals and non-profit higher education research institutions on the project, Cuomo said. There is no cure for Alzheimer’s disease, which affects more than 5 million people in the United States. Current drugs only temporarily reduce symptoms, the AP reported. Copyright © 2019 HealthDay. All rights reserved. QUESTION One of the first symptoms of Alzheimer’s disease is __________________. See Answer
An artificial intelligence tool taught to analyze brain scans can accurately predict Alzheimer’s disease several years before a final diagnosis. Researchers used PET scans to train a deep learning algorithm to predict signs of Alzheimer’s. The team responsible suggests that, after further validation, the tool could greatly assist the early detection of Alzheimer’s, giving treatments time to slow the disease more effectively. The researchers, from the University of California in San Francisco, used positron-emission tomography (PET) images of 1,002 people’s brains to train the deep learning algorithm. They used 90 percent of the images to teach the algorithm how to spot features of Alzheimer’s disease and the remaining 10 percent to verify its performance. They then tested the algorithm on PET images of the brains of another 40 people. From these, the algorithm accurately predicted which individuals would receive a final diagnosis of Alzheimer’s. On average, the diagnosis came more than 6 years after the scans. In a paper on the findings, which the Radiology journal has recently published, the team describes how the algorithm “achieved 82 percent specificity at 100 percent sensitivity, an average of 75.8 months prior to the final diagnosis.” “We were very pleased,” says co-author Dr. […]
Latest Alzheimer’s News WEDNESDAY, Dec. 4, 2019 (HealthDay News) — Cross-country skiing may be good for your brain, a new study suggests. Previous research found that participants of the Vasaloppet, a popular long-distance, cross-country skiing race in Sweden, have a lower risk of heart attack, but potential brain benefits have been unclear. This new research compared the brain health of about 200,000 who took part in the Vasaloppet between 1989 and 2010 and a control group from the general population. Compared with the control group, 50% fewer skiers developed vascular dementia over two decades, the study found. (Vascular dementia is caused by a series of small strokes.) However, the skiers’ risk of Alzheimer’s disease was not lower — a finding that contradicts other studies showing that physical activity may modify Alzheimer’s risk. Researchers said 233 skiers developed dementia, including 40 with vascular dementia and 86 with Alzheimer’s. In the general population, 319 developed dementia, including 72 with vascular dementia and 95 with Alzheimer’s. “As brain researchers, we have had the unique opportunity to analyze an exceptionally large group of very physically active people over two decades, and we have unraveled some interesting results,” said research team leader Tomas Deierborg, an […]
Latest Alzheimer’s News SUNDAY, Nov. 3, 2019 (HealthDay News) — It happens to everyone: A familiar song comes on the radio, and suddenly you recall every note and every word. Now, new research has pinpointed exactly how long it takes people to recognize that favorite tune — just 0.1 to 0.3 seconds. The study included five men and five women who each provided a list of five familiar songs that they associated with good memories. The researchers then chose one of each participants’ songs and matched it with a song that was similar in tempo, melody, harmony, vocals and instrumentation, but was unfamiliar to the participant. Each participant was randomly played 100 snippets (each less than a second) of both the familiar and unfamiliar song. The researchers monitored the participants’ electrical activity in the brain and their pupil diameter (a measure of arousal) while they listed to the song snippets. Song recognition was first revealed by pupil dilation likely associated with increased arousal triggered by the familiar song, followed by brain activity related to memory retrieval, according to the study published online Oct. 30 in the journal Scientific Reports. A “control group” of people unfamiliar with any of the songs […]
WEDNESDAY, May 15, 2019 (HealthDay News) — Regular exercise, eating a healthy diet, watching your blood pressure, avoiding tobacco and limiting alcohol intake can reduce your risk of dementia, according to World Health Organization guidelines released Tuesday. Latest Alzheimer’s News The WHO also cautioned against taking dietary supplements such as Vitamins B and E in an attempt to prevent mental decline and dementia, CNN reported. Dementia affects 50 million people worldwide and there is no effective treatment. “While some people are unlucky and inherit a combination of genes that makes it highly likely they will develop dementia, many people have the opportunity to substantially reduce their risk by living a healthy lifestyle,” Tara Spires-Jones, U.K. Dementia Research Institute program lead and deputy director of the Center for Discovery Brain Sciences at the University of Edinburgh, U.K. told the Science Media Center, CNN reported. “The WHO has looked at the available evidence and made recommendations that some lifestyle changes, in particular increasing exercise before any cognitive symptoms are present, can reduce dementia risk,” she explained. In terms of healthy eating, the WHO said your best bet is the Mediterranean diet, which emphasizes lots of fruits and vegetables and olive oil, CNN […]
According to recent research in vitro and in mice, viruses that come into contact with biological fluids acquire a protein coating that renders them more infectious. Moreover, it seems that some viruses that ‘change identity’ in this way may promote neurodegenerative conditions, such as Alzheimer’s. Research shows that viruses can acquire a protein ‘coating’ that makes them more infectious. Viruses are strange, fascinating agents, not least because scientists still find it difficult to say whether they qualify as living organisms or not. To replicate, viruses have to infect a host — so in a live biological environment, viruses are also “alive,” interacting with the cells of the host they infect and multiplying. At the same time, on their own, outside an infected host, viruses are more “dead” than “alive,” since they are a protein “package,” containing specific genetic material. Though not clearly “dead” or “alive,” viruses can exploit certain biological mechanisms to preserve their integrity and be more likely to replicate. In a new study that used both human biological samples and mice, researchers from Stockholm University and Karolinska Institutet in Solna, Sweden, have been looking at one such phenomenon that allows viruses to become more infectious, namely, the formation […]
An Alzheimer’s diagnosis often relies on signs of memory problems. However, these issues usually do not appear until years after the disease has taken hold. A new smartphone game is using spatial navigation to detect Alzheimer’s before it is too late. A simple game that people can play on their smartphones could help detect Alzheimer’s risk. Another person develops Alzheimer’s disease every 3 seconds, according to Alzheimer’s Disease International. The number of people living with this most common form of dementia currently stands at around 50 million. By 2050, experts expect this figure to have tripled. The last “significant breakthrough” in Alzheimer’s research happened 4 decades ago, states the latest World Alzheimer’s Report. However, a recently developed smartphone game may alter that statistic. “Research shows us that the brain changes associated with diseases like Alzheimer’s begin decades before symptoms like memory loss start,” says Hilary Evans, chief executive at Alzheimer’s Research United Kingdom. “[F]or future Alzheimer’s treatments to be effective, it’s likely they must be given at the earliest stages of disease, before there’s too much damage to the brain.” Navigating space A collaboration between the organization, the University of East Anglia (UEA) and University College London in the U.K., […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News FRIDAY, April 19, 2019 (HealthDay News) — Alzheimer’s and dementia are not an inevitable part of normal aging, and a little exercise might help keep them at bay, a new study suggests. The researchers found that every hour of light exercise on top of recommended weekly levels of more intense activity reduced brain aging by about a year. “This study emphasizes the relationship we are seeing between people doing more light-intensity physical activity and also having maintained brain structures,” said lead researcher Nicole Spartano. She added that the study shows a link but does not prove that physical activity keeps the brain healthy. “We can’t be certain that physical activity is causing people to have a better brain structure,” said Spartano, a research assistant professor at Boston University School of Medicine. Though it’s not clear how much exercise is needed to keep your brain in peak condition, this study suggests that the bar is lower than thought. Spartano’s team suspects a moderate amount of low-intensity activity may do the trick. For the study, Spartano and her colleagues collected data on more than 2,300 men and women, average age 53, who each wore a […]
The results of a new study suggest that virtual reality could make life easier for people with dementia. The authors conclude that virtual reality helped the participants recall memories and contributed to an improvement in patients’ relationships with caregivers. Could virtual reality enhance the lives of people with dementia? Dementia is an umbrella term for a range of conditions, including Huntington’s and Alzheimer’s diseases. It can cause memory loss so severe that it negatively impacts a person’s ability to perform day-to-day activities. A person’s risk of dementia increases as they get older, and a person can be more prone to developing Alzheimer’s based on their ethnicity. For instance, according to the Centers for Disease Control and Prevention (CDC), African Americans are the group most at risk for Alzheimer’s among seniors, followed by Hispanic people, then non-Hispanic white people. The CDC state that the greatest increase in Alzheimer’s disease over the coming decades will occur among Hispanic and African American people and that these increases are largely due to people living longer, as the rates of people dying from chronic diseases are decreasing. Virtual environments triggered memories In the current study, the researchers — many from the University of Kent in […]
More evidence points to the idea that air pollution may increase the risk of Alzheimer’s disease. A new study suggests that tiny polluting particles carried by dirty air can enter the brain, possibly contributing to cognitive decline. Share on PinterestWomen living in highly polluted areas are likelier to experience cognitive decline. It is no secret that ambient air pollution is an important risk factor for various health concerns. According to the World Health Organization (WHO), 9 in every 10 people worldwide breathe highly polluted air. Importantly, poor air quality contributes to millions of deaths globally per year. Although it is easy to understand how the air we breathe might affect our respiratory system — with research showing that ambient pollution contributes to lung cancer — it can be harder to understand how, or even if it impacts the health of other major organs. In fact, an increasing amount of evidence suggests that air pollution is associated with cognitive decline, and that it may contribute to the ever growing number of Alzheimer’s disease cases. For example, one study that Medical News Today covered in 2018 suggests that people with the most exposure to top air pollutants have a higher risk of […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News MONDAY, June 17, 2019 (HealthDay News) — Treatment with blood pressure medication can improve blood flow to a key brain region in people with Alzheimer’s disease, a small clinical trial has found. Researchers stressed that they do not know whether the brain finding can translate into any benefits for patients. But future studies should look into that possibility, they said. The findings, published June 17 in the journal Hypertension, come from a trial of 44 patients with mild to moderate Alzheimer’s. They were randomly assigned to take either the blood pressure drug nilvadipine or inactive placebo pills for six months. In the end, patients on the drug showed a 20% increase in blood flow to the hippocampus — a brain structure involved in memory and learning that is one of the first areas damaged by Alzheimer’s. Experts said the study was too small and short-term to know whether the improved blood flow could have any effect on symptoms. But future research should try to answer that question and should focus on people with early Alzheimer’s, said Dr. Jurgen Claassen, the study’s lead author. The research is part of a larger trial that looked […]
Latest Alzheimer’s News SUNDAY, Nov. 25, 2018 (HealthDay News) — People caring for a loved one with Alzheimer’s or other types of dementia should focus on four main safety issues, an expert says. Nearly 6 million Americans have Alzheimer’s disease, according to the Alzheimer’s Association. About 16.1 million Americans provide unpaid care for people with Alzheimer’s or other dementias. “When approaching dementia families, I follow the safe and sane rule,” said Dr. Andrew Duxbury, a geriatrician in the Division of Gerontology, Geriatrics and Palliative Care at University of Alabama at Birmingham. “Everything we do needs to make the patient safe and the family sane. In terms of safety, it boils down into the big four: meals, wheels, bills and pills,” he explained in a university news release. In terms of meals, caregivers need to consider whether the person is capable of preparing food, eating healthy and appropriate amounts of food, and has the awareness that they need to eat, Duxbury said. “If any link in that chain breaks, the person may not eat,” he said. When it comes to kitchen safety, the “biggest issue is leaving things on the stove and forgetting to turn the oven off; but if cooking […]
Latest Alzheimer’s News MONDAY, Nov. 26, 2018 (HealthDay News) — An experimental Alzheimer’s disease vaccine shows promise in animal tests, and researchers say it could have the potential to reduce dementia cases by half. In mice created to develop Alzheimer’s, the vaccine triggered an immune response that reduced accumulation of two toxic proteins associated with the fatal brain disease. There was a 40 percent reduction in beta-amyloid proteins and up to a 50 percent reduction in tau proteins, with no harmful side effects, according to researchers at the University of Texas. But there’s a catch: While such tests showed positive results in mice, research on animals doesn’t always produce the same effects in humans. More study is needed. Still, the researchers remained optimistic. Reductions in these proteins could someday have significant benefits in people at risk for Alzheimer’s disease, said study senior author Doris Lambracht-Washington, of the UT Southwestern Medical Center Brain Institute in Dallas. “If the onset of the disease could be delayed by even five years, that would be enormous for the patients and their families,” she said in a center news release. “The number of dementia cases could drop by half.” Lead researcher Dr. Roger Rosenberg is […]
(HealthDay News) — Memory loss is common, but should not be taken lightly, says Mayo Clinic. If you have difficulty remembering things, Mayo Clinic offers a few simple ways to sharpen your memory: Stay physically and mentally active. Socialize often. Stay organized. Sleep well. Eat healthy. Manage chronic conditions. Latest Alzheimer’s News If memory loss affects your ability to complete your daily activities, or if you notice it getting worse, talk with your doctor. Copyright © 2019 HealthDay. All rights reserved.
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News TUESDAY, Jan. 29, 2019 (HealthDay News) — Tight control of your blood pressure won’t necessarily spare you from full-blown dementia, a new trial concludes. But it might lower the risk of slight declines in thinking and memory, a condition known as mild cognitive impairment (MCI), the researchers added. The clinical trial is the “first study in history to show that any intervention can reduce your risk of developing mild cognitive impairment, an early form of dementia,” said lead researcher Dr. Jeff Williamson. He is a professor of gerontology and geriatric medicine at Wake Forest School of Medicine, in Winston-Salem, N.C. “What is good for your heart in terms of blood pressure-lowering is also good for your brain,” Williamson added. He noted that the trial ended early, which likely affected the dementia result. “We just didn’t have enough dementia cases develop over time” in the group with less-restricted blood pressure, he explained. High blood pressure affects more than three-fourths of people over the age of 65, and it has been identified as a potential risk factor for MCI and dementia in observational studies, the study authors said in background notes. The new clinical trial […]
New research in mice reveals the mechanisms through which two experimental drugs that may treat Alzheimer’s disease have broader, anti-aging properties and can reverse age-related cognitive decline. Share on PinterestNew research explains how two experimental dementia drugs may reverse normal aging. Family history, genes, and some lifestyle choices all influence a person’s risk of Alzheimer’s disease, but age is the greatest risk factor that researchers are aware of. Most people who receive a diagnosis of Alzheimer’s are at least 65 years old. In fact, after that age, the risk of developing the condition doubles every 5 years. However, scientists do not yet fully understand, on a molecular level, how aging is involved in driving Alzheimer’s. Previous research has shown that faulty glucose metabolism in the brain occurs before the onset of Alzheimer’s symptoms. Cerebral glucose metabolism declines with age anyway, but in Alzheimer’s, the decline is much more severe. Furthermore, other studies have shown that dysfunctional mitochondria in the brain’s cells are a hallmark of both normal aging and Alzheimer’s. Armed with this knowledge, researchers from the Salk Institute for Biological Studies and the Scripps Research Institute — both in La Jolla, CA — set out to test several drugs […]
Recent research has found that short daily practice of mind-body therapy may help alleviate some of the signs and symptoms that often precede dementia. Practicing an easy type of meditation daily may relieve some dementia symptoms. The researchers behind the new study assessed a group of older adults experiencing memory difficulties who practiced 12 minutes per day of music listening or simple yoga meditation for 12 weeks. Samples of their blood from before and after the 3 months of therapy revealed changes in levels of certain markers with associations to cell aging and Alzheimer’s disease. These changes also linked directly to improvements in subjective assessments of cognitive function, mood, sleep, and quality of life. Dr. Kim Innes, a professor at West Virginia University School of Public Health in Morgantown, led the study and is first author of the study paper, which features in the Journal of Alzheimer’s Disease. Blood markers as predictors of Alzheimer’s The team chose to measure a number of blood markers that “have emerged as possible predictors of cognitive decline and dementia.” These included telomere length, telomerase activity, and levels of certain beta-amyloid peptides with links to Alzheimer’s disease. Telomeres are “protective caps” that work to prevent […]
As scientists delve deeper into the nature of Parkinson’s, the more it appears that it is highly varied, suggesting numerous subtypes. A new review proposes that Parkinson’s falls into one of two main categories, depending on whether it originates in the central nervous system (CNS) or the peripheral nervous system (PNS). Share on PinterestNew research redefines Parkinson’s disease. In a recent Journal of Parkinson’s Disease paper, scientists from Denmark argue how results from imaging and tissue studies fit with a theory of Parkinson’s that divides the condition “into a PNS-first and a CNS-first subtype.” Parkinson’s disease principally destroys dopamine cells in the brain’s substantia nigra area. This is the part that controls movement. This damage gives rise to the most common symptoms, including tremors, rigidity, and balance difficulties. Parkinson’s disease may also cause emotional changes, depression, constipation, sleep disruption, and urinary problems. The pattern of symptoms and their rate of progression can vary widely among individuals. A distinguishing feature of Parkinson’s, however, is the accumulation and spread of toxic clumps of alpha-synuclein protein called Lewy bodies. These clumps are also hallmarks of dementia with Lewy bodies. Debating the origins of Parkinson’s Some scientists have proposed that the toxic alpha-synuclein forms […]
Researchers found that using a computer, playing games, and participating in social activities may reduce the risk of mild cognitive impairment. New research suggests that playing games, using a computer, and having a rich social life can keep mild cognitive impairment at bay. Our brains go through changes as we get older, and some people may experience issues with memory, thinking, or judgment. Mild cognitive impairment (MCI) is the stage between age-related cognitive decline and dementia — however, MCI does not significantly affect daily life and activities. People with MCI tend to forget things, lose their train of thought or the thread of conversations, and feel overwhelmed by making decisions. According to the Centers for Disease Control and Prevention (CDC), more than 16 million people in the United States are living with cognitive impairment. MCI may increase the risk of dementia, but not everyone with MCI goes on to develop the condition. To date, the Food and Drug Administration (FDA) have not approved any treatments specifically for MCI. Lifestyle choices such as physical exercise and intellectual stimulation have positive effects on the brain. In recent years, researchers have been conducting more studies to find treatments that may prevent cognitive decline. […]
(HealthDay News) — Dementia is a group of symptoms associated with a decline in memory or thinking skills. Latest Alzheimer’s News Because the progression of dementia varies, deciding when a person is no longer able to drive safely can be difficult, says the National Center on Caregiving. For caregivers and those who have a loved one with dementia, the center suggests: If the person has mild dementia, have driving skills evaluated immediately. If the person with dementia passes, continue to have driving skills evaluated every 6 months. Watch for behavioral signs, such as disorientation and difficulty processing. Watch for poor driving behavior, such as drifting or incorrect signaling. Encourage the person to drive on familiar roads, and avoid nighttime driving. The NCC also suggests reducing the need to drive by arranging alternative transportation. Copyright © 2019 HealthDay. All rights reserved. SLIDESHOW Dementia, Alzheimer’s Disease, and Aging Brains See Slideshow
By Alan MozesHealthDay Reporter Latest Alzheimer’s News THURSDAY, June 27, 2019 (HealthDay News) — Every college student misplaces keys or forgets an appointment from time to time. Usually it’s no big deal. But a new study warns that when young people with a family history of Alzheimer’s disease have memory lapses, it could be an early sign of something serious. That’s the concern raised by a new memory test taken by nearly 60,000 men and women between the ages of 18 and 85. The results revealed that participants between 18 and 65 who had family members with Alzheimer’s scored lower than those who did not. That included even young adults in their 20s. But, “no one should feel doomed to experience Alzheimer’s, certainly not simply because your parents or grandparents were diagnosed with the disease,” stressed study author Matt Huentelman. He is a professor of neurogenomics with TGen, a genetics research institute based in Phoenix. Lots of non-inherited factors play a role in Alzheimer’s risk, he explained. And, “there are many cases of people with family history and/or high genetic risk for Alzheimer’s who live long lives without memory problems.” But there’s no getting around the fact that roughly 75% […]
(HealthDay News) — It’s taking you longer than it once did to learn a new task. Or you’ve forgotten about today’s doctor’s appointment. Should you be worried? Latest Alzheimer’s News In other words, do you have mild forgetfulness or symptoms of a more serious memory problem? The National Institute on Aging says you should speak to your doctor, who can help determine if your memory and thinking problems are normal or not, and what might be causing them. Signs of a more serious memory issue include: Asking the same questions repeatedly. Getting lost in familiar places. Not being able to follow instructions. Becoming confused about time, people or places. Copyright © 2018 HealthDay. All rights reserved.
Research showed that an antibiotic mix impacted the gut bacteria in mice to the point that it slowed the growth and development of Alzheimer’s, but only in males. New research in mice suggests that antibiotics may reduce Alzheimer’s symptoms by impacting the gut bacteria. The study, conducted at The University of Chicago, IL, demonstrated how long-term antibiotic use could reduce inflammation and slow the growth of amyloid plaques in male mice. Amyloid plaques are a feature specific to Alzheimer’s disease. They form when a particular protein within the neurons of the brain buildup and clump together. These amyloid plaques disrupt brain cell function and lead to the symptoms of Alzheimer’s. The team was led by Professor Sangram S. Sisodia, who is also the director of the Center for Molecular Neurobiology at The University of Chicago. The team was already aware that people with Alzheimer’s showed changes in their gut bacteria, and they had previously carried out studies showing how gut bacteria could potentially affect Alzheimer’s-like symptoms in rodents. This research found that changes to the microbiome limited the development of amyloid plaques in male mice, but not females. Sisodia says of the research that “[w]hile compelling, our published studies on […]
Scientists have now proved that drinking certain types of coffee can be beneficial to brain health, but how does this popular brew support cognitive function? A new study identifies some of the mechanisms that allow coffee to keep mental decline at bay. What makes coffee an ally of brain health? According to data from the Harvard T.H. Chan School of Public Health in Boston, MA, about 54 percent of all adults in the United States drink coffee on a daily basis. While drinking coffee can bring both benefits and risks for a person’s health, a 2016 study from the University of Ulster in Coleraine, United Kingdom, concluded that the health benefits of moderate coffee consumption “clearly outweigh” the potential risks. One of these benefits is that coffee seems to protect the brain against cognitive impairments and boost thinking skills. How does this happen, and what is it about coffee that is so beneficial to cognitive health? These are some questions that a new study from the Krembil Brain Institute — part of the Krembil Research Institute in Toronto, Canada — aims to answer. “Coffee consumption does seem to have some correlation to a decreased risk of developing Alzheimer’s disease and […]
Latest Alzheimer’s News WEDNESDAY, May 29, 2019 (HealthDay News) — New research delivers fresh hope for everyone who struggles with a fading memory: Neurons continue to form well into old age, even in people with mental impairments or Alzheimer’s disease. “We found that there was active neurogenesis [new neurons forming] in the hippocampus of older adults well into their 90s,” said study author Orly Lazarov, a professor of anatomy and cell biology at the University of Illinois at Chicago. “The interesting thing is that we also saw some new neurons in the brains of people with Alzheimer’s disease and cognitive [thinking] impairment,” she added in a university news release. The findings could lead to new treatments for mental decline in older adults, the researchers said. In the study, Lazarov and her colleagues examined hippocampus tissue from the brains of 18 people, average age 90.6 years, after they died. The hippocampus is involved in the formation of memories and in learning. On average, there were about 2,000 neural stem cells and 150,000 developing neurons in each brain. While people with mental impairments and Alzheimer’s disease did have new neurons, their levels were significantly lower than in people with normal brain function, […]
Previous research suggested that hearing loss and abnormalities in the eye are tied to memory loss and a higher Alzheimer’s risk. New evidence now indicates that addressing hearing and sight problems can slow down cognitive decline. Opting for hearing aids and cataract surgery can make a big difference when it comes to slowing down cognitive decline. Existing studies have pointed out that there is a link between the quality of a person’s hearing and their eye health and their exposure to cognitive decline. For instance, one such study covered on Medical News Today suggested that poor hearing may correlate with a poor memory. Another one proposed that we could detect Alzheimer’s disease by looking for tell-tale abnormalities in a person’s eyes. Now, two new papers — each based on studies conducted by the same scientists from the University of Manchester in the United Kingdom — look at the evidence indicating that treating hearing loss and eyesight problems can slow down the development of cognitive decline. One of the papers, published in the journal PLOS One, shows that people who have had surgery for cataract — which is condition that can lead to vision loss in the absence of a surgical […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News THURSDAY, Dec. 20, 2018 (HealthDay News) — Walking and other types of moderate exercise may help turn back the clock for older adults who are losing their mental sharpness, a new clinical trial finds. The study focused on older adults who had milder problems with memory and thinking skills. The researchers found that six months of moderate exercise — walking or pedaling a stationary bike — turned some of those issues around. Specifically, exercisers saw improvements in their executive function — the brain’s ability to pay attention, regulate behavior, get organized and achieve goals. And those who also made some healthy diet changes, including eating more fruits and vegetables, showed somewhat bigger gains. The effect was equivalent to shaving about nine years from their brain age, said lead researcher James Blumenthal, a professor at Duke University School of Medicine, in Durham, N.C. In contrast, those same mental abilities kept declining among study participants who received health education only. Experts said the findings support the general concept that a healthy lifestyle can help protect the brain as you age. “And it’s never too late to start,” said Keith Fargo, director of scientific programs and […]
Experts have already concluded that exercise can help people with Parkinson’s disease improve their motor symptoms, but what is its effect on the cognitive symptoms of this condition? Besides boosting motor function, exercise could improve memory in people with Parkinson’s disease. Parkinson’s disease is a neurological condition that usually stands out for the motor symptoms that it causes, which include tremors, rigidity in the limbs, impaired balance, and a lack of control over movements. However, this condition also has numerous other symptoms that can leave their mark on a person’s quality of life. Cognitive symptoms, in particular, have been worrying researchers interested in the pathology of Parkinson’s disease. People with this condition experience cognitive impairment, which can worsen in time and eventually evolve into Alzheimer’s disease. When it comes to managing Parkinson’s, doctors often advise their patients to take up an exercise regime, since physical activity demonstrably helps improve motor symptoms. The Parkinson’s Foundation call exercise routines “a vital component” of efforts to maintain the quality of life following diagnosis. But how does physical activity affect other symptoms of Parkinson’s disease, particularly cognitive ones? This is the question that a team of researchers from the German Sport University, in Cologne, […]
Memory can deteriorate naturally, due to age, and even when this process is not related to neurodegenerative conditions, such as Alzheimer’s, it can still affect a person’s quality of life. Now, researchers from Boston University in Massachusetts are exploring ways of fighting age-related memory decline. By resynchronizing brain waves, we could reverse some age-related memory problems. “Working memory […] is a fundamental building block of human cognition,” explains Robert Reinhart, Ph.D., the director of the university’s Visual Cognitive Neuroscience Laboratory. “It’s been called, classically, the ‘workbench of the mind’ or the ‘sketchpad of the mind.’ It allows us to hold information in our minds over a period of seconds,” he continues. Essentially, this is the type of memory that allows a person to make spontaneous calculations and assessments, and navigate daily life situations. But working memory also starts to naturally decline with age, which means that, as a person grows older, they may find it more difficult to perform some tasks, such as keeping track of their finances. “Working memory […] is where we think, where we problem-solve, where we reason, plan, perform mathematical calculations, make decisions. It’s essentially where consciousness lives.” Robert Reinhart, Ph.D. For this reason, Reinhart and […]
A novel genetic approach that repairs broken connections between brain cells could lead to treatments that restore memory capacity in Alzheimer’s disease. By using epigenetics, it may soon be possible to reverse memory loss in Alzheimer’s disease. The new approach reverses changes to gene expression that tend to occur in the later stages of the disease. Scientists at State University of New York at Buffalo demonstrated how the method was able to reverse Alzheimer’s memory decline in mice. Much genetic research on the causes of Alzheimer’s disease focuses on changes in the DNA of genes. The new study, however, focuses on epigenetics, which concerns mechanisms that can switch genes on and off without disturbing their DNA code. A paper about the work now features in the journal Brain. “In this paper,” says senior study author Zhen Yan, Ph.D., who is a professor in the Department of Physiology and Biophysics, “we have not only identified the epigenetic factors that contribute to the memory loss, we also found ways to temporarily reverse them in an animal model of [Alzheimer’s disease].” Alzheimer’s disease and loss of synapses Alzheimer’s disease is the leading cause of dementia. According to the World Health Organization (WHO), between […]
PET scans that can detect changes in the brain relating to Alzheimer’s disease could improve the diagnosis and medical care of people with dementia and similar symptoms. An innovative type of brain scan may improve care for people with Alzheimer’s disease, dementia, and other forms of cognitive impairment. Investigators came to this conclusion after analyzing the early results of a study that is examining the clinical impact of a new type of scan called amyloid PET imaging. The study is a nationwide trial involving more than 11,000 people with mild cognitive impairment (MCI) or dementia symptoms who enrolled at 595 sites across the United States. It is the first investigation of its kind, and all the participants are beneficiaries of Medicare, the U.S. federal health insurance plan. The results of the first phase of the trial, which now feature in a JAMA paper, reveal that providing doctors with amyloid PET scan results can affect the medical management of people with dementia symptoms. In almost two-thirds of cases, doctors changed their minds about medications, counseling, and other medical decisions after seeing the amyloid PET imaging results. Also, in more than a third of cases, doctors altered their diagnosis of the cause […]
Latest Alzheimer’s News WEDNESDAY, March 27, 2019 (HealthDay News) — A dementia study has led researchers to a brain region that processes spoken, not written, words. Northwestern University researchers worked with four patients who had a rare type of dementia called primary progressive aphasia (PPA), which destroys language. Although able to hear and speak, they could not understand what was said out loud. However, they could still process written words. For example, if they read the word “hippopotamus,” they could identify a picture of a hippo. But if someone said the word “hippopotamus,” they couldn’t point to its picture. Through their tests with these patients, the researchers were able to identify an area in the left brain that appears specialized to process spoken words. “We always think of these degenerative diseases as causing widespread impairment, but in early stages, we’re learning that neurodegenerative disease can be selective with which areas of the brain it attacks,” said senior author Sandra Weintraub. She’s a professor of psychiatry and behavioral sciences and neurology at Northwestern’s Feinberg School of Medicine in Chicago. “The fact that only the auditory words were impaired in these patients and their visual words were untouched leads us to believe […]
Ketogenic, or keto, diets are low-carb and fat-rich, and many people who follow such regimens do it to shed excess weight. However, a keto diet may bring other benefits, too. In particular, it may help keep the brain healthy and young, as new research in mice seems to suggest. Can a keto diet protect brain health, and if so, how? A keto diet is high in fat, low in carbohydrates, and has an adequate amount of protein. This kind of diet is meant to trigger ketosis, which is a metabolic process through which the body breaks down fat and protein and transforms them into energy, leading to weight loss. Besides triggering weight loss, a keto diet may also bring other health benefits, as studies have recently suggested. For instance, one such study argued that keto diets could help reduce the side effects of certain cancer therapies. Now, researchers from the Sanders-Brown Center on Aging at the University of Kentucky in Lexington, KY, are assessing evidence suggesting that keto diets may also help stave off cognitive decline. The scientists conducted two studies, both in mice. The findings indicate that keto-type diets can protect neurovascular function, as well as metabolic function, in […]
Although a vaccine for dementia is a long way down the road, researchers recently made a few tentative steps closer. The authors of a recent study in mice hope that in the coming years, they can move into human trials. Share on PinterestScientists believe that they are on the path to a vaccine against dementia. Globally, dementia affects an estimated 50 million people. Because dementias are primarily a disease of older age, this figure is likely to increase as the average life expectancy increases. In fact, some scientists have calculated that the burden of dementia in the United States could double by the year 2060. Alzheimer’s disease, which is the most common form of dementia, is characterized by changes in the brain. Specifically, there is a buildup of beta-amyloid, which is a protein that produces amyloid plaques. Similarly, another protein, known as tau, accumulates to form neurofibrillary tangles. Together, these proteins drive cognitive decline and neurodegeneration. Currently, there is no cure for dementia, and treatments are limited. Over the years, several promising drug candidates have proven unsuccessful in human trials. A preemptive strike The authors of the current study believe that one of the reasons that experimental drugs have failed […]
Latest Alzheimer’s News By Steven ReinbergHealthDay Reporter MONDAY, Dec. 2, 2019 (HealthDay News) — Playing cards and board games like chess, bingo and Scrabble might be the mental workout you need to keep your wits as you age, Scottish researchers suggest. People in their 70s who regularly play board games score higher on tests of memory and thinking skills than those who don’t. And 70-somethings who step up their game-playing are more likely to maintain thinking skills as they age, researchers say. “Playing board, card and word games may protect people from cognitive decline, but this study wasn’t an intervention, so we can’t say that for sure,” said lead researcher Drew Altschul, a postdoctoral research fellow at the University of Edinburgh. “But it, at very least, is fun, inexpensive, and it certainly won’t hurt you.” He doesn’t think it’s the social aspect of these activities that provides this brain-protective effect, but rather the challenge of the games themselves. Unlike reading, writing, taking classes, visiting museums, libraries or friends and relatives, games appear to more actively engage abilities like memory, thinking speed and reasoning, Altschul said. “So, this fits with what we call the ‘use it or lose it’ theory, that […]
By Peter Schelden on 11/08/2019 2:29 PM Latest Alzheimer’s News Source: MedicineNet Health News People with Down syndrome seem to face a much greater risk of dementia — particularly Alzheimer’s disease — than previously known, according to new research. And they often exhibit symptoms much earlier in life. For the first time, researchers inspected Medicaid claims to show how common these memory conditions are in the lives of people with Down syndrome above age 40. Claims records for nearly 3,000 Wisconsin Medicaid enrollees with Down syndrome were analyzed. Investigators found that 40% of 40 to 54 year olds with Down syndrome have made claims for dementia, and 27% specifically made claims for Alzheimer’s, a type of dementia. In comparison, people over the age of 60 have a 5% to 8% dementia rate in the general population, according to the World Health Organization. This research goes beyond prior studies by examining real cases from a large, diverse group, said Chief of NICHD’s Intellectual and Developmental Disabilities Branch Melissa Parisi, M.D., Ph.D. Other approaches might leave out patients who seek care from more expensive health providers. The study could encourage investigators to search for similar patterns in other states. Dr. Parisi said […]
Latest Alzheimer’s News TUESDAY, Jan. 22, 2019 (HealthDay News) — Leaky blood vessels in the brain may be an early sign of Alzheimer’s disease, researchers say. They followed 161 older adults for five years and found that those with the most severe memory declines had the greatest leakage in their brain’s blood vessels, regardless of whether the Alzheimer’s-related proteins amyloid and tau were present. The findings could help with earlier diagnosis of Alzheimer’s and suggest a new drug target for slowing down or preventing the disease, according to the researchers from the University of Southern California. “The fact that we’re seeing the blood vessels leaking, independent of tau and independent of amyloid, when people have cognitive [mental] impairment on a mild level, suggests it could be a totally separate process or a very early process,” said study senior author Dr. Berislav Zlokovic. He is director of the Zilkha Neurogenetic Institute at the university’s Keck School of Medicine in Los Angeles. “That was surprising, that this blood-brain barrier breakdown is occurring independently,” Zlokovic added in a university news release. The blood-brain barrier prevents harmful substances from reaching brain tissue. In some people, this barrier weakens with age. “If the blood-brain barrier […]
New research that aimed to highlight the potential of new technologies to diagnose disease has suggested that virtual reality may play a crucial role in monitoring Alzheimer’s disease. VR headsets may soon serve as a better alternative to standard testing for Alzheimer’s. Dementia is a general term to describe the impairment of cognitive functions such as memory, thinking, and communication. The cognitive decline associated with dementia is progressive, and people may go through different stages. Mild cognitive impairment (MCI) is an early stage of dementia, but some people with MCI do not develop Alzheimer’s disease. MCI can result from anxiety or normal aging, so it is important to establish the cause to evaluate the risk of dementia. Alzheimer’s is the most common type of dementia. According to the World Health Organization (WHO), about 50 million people in the world have dementia. Doctors diagnose dementia in around 10 million people every year, and 60–70% of these new diagnoses detect Alzheimer’s disease. Several cognitive tests can assess dementia, but recently, researchers have been exploring the potential of new technologies to monitor the condition. A new study from Cambridge University in the United Kingdom — the results of which now appear in the […]
You have chosen to share the following article: How elderberries can help you fight the flu To proceed, simply complete the form below, and a link to the article will be sent by email on your behalf.Note: Please don’t include any URLs in your comments, as they will be removed upon submission. We do not store details you enter into this form. Please see our privacy policy for more information. Message sent successfully The details of this article have been emailed on your behalf. Click here to return to the Medical News Today home page.
New research has shown that impaired insulin signaling in the brain, often a feature of diabetes, may negatively impact cognition, mood, and metabolism — all of which are common aspects of Alzheimer’s disease. A new study examines the links between Alzheimer’s and diabetes. Although the conditions are seemingly independent of each other, earlier studies have found that people with type 2 diabetes are more likely to develop Alzheimer’s disease. However, the mechanisms behind this relationship have remained hidden. A recent study investigated the impact of blocking insulin receptors and insulin-like growth factor (IGF1) receptors in mouse models. The work was carried out at the Joslin Diabetes Center, affiliated with Harvard Medical School in Boston, MA. The results reveal that interrupting these similar pathways impaired both learning and memory. The researchers published their findings in the Proceedings of the National Academy of Sciences. Insulin receptors and learning The researchers worked with both the hippocampus and the central amygdala, areas of the brain that help with cognition function, as well as metabolic control. They looked into how mice with disabled insulin and IGF1 receptors tackled mazes, and the results were revealing. First, the researchers allowed the mice to explore the maze to […]
Latest Alzheimer’s News THURSDAY, May 16, 2019 (HealthDay News) — Mornings spent figuring out Sudoku or finessing a crossword could spell better health for aging brains, researchers say. In a study of over 19,000 British adults aged 50 and over who were tracked for 25 years, the habit of doing word or number puzzles seemed to help keep minds nimble over time. “We’ve found that the more regularly people engage with puzzles such as crosswords and Sudoku, the sharper their performance is across a range of tasks assessing memory, attention and reasoning,” said research leader Dr. Anne Corbett, of the University of Exeter Medical School. “The improvements are particularly clear in the speed and accuracy of their performance,” she added in a university news release. “In some areas, the improvement was quite dramatic — on measures of problem-solving, people who regularly do these puzzles performed equivalent to an average of eight years younger compared to those who don’t.” Does that translate to protection against Alzheimer’s and other forms of dementia? The study “can’t say” at this point, Corbett said, “but this research supports previous findings that indicate regular use of word and number puzzles helps keep our brains working better […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News MONDAY, Nov. 18, 2019 (HealthDay News) — Concerns that cholesterol-lowering statin drugs can impair brain health appear to be unfounded, according to new research. “Statins won’t make you stupid or cause memory loss,” said lead researcher Dr. Katherine Samaras, a professor of medicine at St. Vincent’s Clinical School of Medicine in Darlinghurst, Australia. And for some people at risk of dementia, statins like Lipitor (atorvastatin) and Crestor (rosuvastatin) may improve memory and mental functioning, her team found. Many millions of people take statins because of heart disease or high cholesterol. But reports that the drugs could cause memory loss led the U.S. Food and Drug Administration in 2012 to require a black box warning on all statin medications, she said. However, “we could find no overall impact on memory or any other aspect of cognitive function over six years in a large population of older people, who had extensive testing every two years,” Samaras said. The observational nature of this study means the research can’t be considered conclusive, only that a strong link exists, the researchers noted. “Any person who takes statins and is concerned about their memory and cognition should discuss this […]
Latest Alzheimer’s News THURSDAY, Feb. 6, 2020 (HealthDay News) — A genetic variant associated with Alzheimer’s disease increases the risk of dementia in people with Parkinson’s disease, researchers say. The finding could lead to new treatments for dementia in Parkinson’s patients, according to the team at Washington University School of Medicine in St. Louis. Parkinson’s disease is a progressive neurological disorder that causes tremors, stiffness, slow movement and impaired balance. Eighty percent of patients diagnosed with Parkinson’s develop dementia within 20 years. Those who carry a particular variant of the gene APOE have an especially high risk, the study authors said. The researchers found that Parkinson’s-related proteins spread more rapidly through the brains of mice with the high-risk APOE4 variant, and that memory and thinking skills decline faster in Parkinson’s patients who have the variant. APOE4 is known to increase the risk of Alzheimer’s disease by three to five times. The study was published Feb. 5 in the journal Science Translational Medicine. “Dementia takes a huge toll on people with Parkinson’s and their caregivers,” said lead author Dr. Albert Davis, an assistant professor of neurology. “The development of dementia is often what determines whether someone with Parkinson’s is able to […]
Latest Alzheimer’s News By E.J. MundellHealthDay Reporter MONDAY, Dec. 30, 2019 (HealthDay News) — For decades, scientists have known that Alzheimer’s disease is accompanied by the buildup of clumps of amyloid protein between brain cells. Could these plaques be causing the disease? That’s been a prevailing theory driving Alzheimer’s research for years. But a new study suggests the strategy could be wrong. Researchers reporting Dec. 30 in the journal Neurology have found that early declines in memory and thinking seen in Alzheimer’s patients tend to occur before amyloid plaques begin to appear in the brain, not after. “Our research was able to detect subtle thinking and memory differences in study participants and these participants had faster amyloid accumulation on brain scans over time, suggesting that amyloid may not necessarily come first in the Alzheimer’s disease process,” study author Kelsey Thomas explained in a journal news release. “Much of the research exploring possible treatments for Alzheimer’s disease has focused on targeting amyloid, but based on our findings, perhaps that focus needs to shift to other possible targets,” said Thomas, who conducts research at the VA San Diego Healthcare System. This isn’t the first indication that amyloid plaques might not cause Alzheimer’s […]
There are two major stumbling blocks to developing effective drugs for Alzheimer’s, Parkinson’s, and other diseases that destroy the brain. The first is overcoming the blood-brain barrier, and the second is delivering the drug to a precise location and ensuring that it does not spread to the rest of the brain. New research finds a way to target more precise locations in brains with Parkinson’s. Now, a new approach that uses ultrasound beams and microbubbles could be a noninvasive way to deliver drugs safely to precise locations in the brain. The technique is called focused ultrasound (FUS) and promises to open the door to thousands of drugs that could treat a range of brain conditions if they could cross the blood-brain barrier. The scientists at Columbia University in the city of New York who developed the FUS device have now shown that it helped to curb early Parkinson’s disease progression and improve brain function in mice. They describe the results in a recent Journal of Controlled Release study paper. The FUS technique temporarily opens the blood-brain barrier in a specific part of the brain to allow drugs to reach just that part. Opening the blood-brain barrier The blood-brain barrier is […]
A new study of older adults in a Japanese town has found that those whose blood contained higher levels of trans fats were more likely to develop dementia than those with lower levels. Sweet pastry can be a rich source of trans fats, which may raise the risk of dementia in some people, according to new research. The researchers also found that sweet pastries were likely the biggest source of dietary trans fats in that population. There are two primary sources of trans fats in the human diet: natural and artificial. Natural trans fats are present in small amounts in dairy products and the meat of some animals. Artificial trans fats, or trans fatty acids, are the primary source of trans fats in the diet and are the product of an industrial process that adds hydrogen to vegetable oil to make it solid. According to the American Heart Association, consumption of trans fats can raise the risk of heart disease, stroke, and has links to a higher risk of type 2 diabetes. In a recent Neurology paper, the new study authors describe how they linked trans fats to a higher risk of dementia using data from an ongoing health study […]
What is memantine, and how does it work (mechanism of action)? Memantine is an oral medication for treating patients with Alzheimer’s disease. Other medications used for Alzheimer’s disease affect acetylcholine, one of the neurotransmitter chemicals that nerve cells in the brain use to communicate with one another. These drugs – galantamine (Razadyne – formerly known as Reminyl), donezepil (Aricept), rivastigmine (Exelon), and tacrine (Cognex) – inhibit the enzyme acetylcholinesterase that destroys acetylcholine and thereby increase the effects of acetylcholine. Memantine’s effects are independent of acetylcholine and acetylcholinesterase. Glutamate is the main excitatory neurotransmitter in the brain. It is believed that too much stimulation of nerve cells by glutamate may be responsible for the degeneration of nerves that occurs in some neurological diseases such as Alzheimer’s disease. Like other neurotransmitters, glutamate is produced and released by nerve cells in the brain. The released glutamate then travels to nearby nerve cells where it attaches to a receptor on the surface of the cells called the N-methyl-D-aspartate (NMDA) receptor. Memantine blocks this receptor and thereby decreases the effects of glutamate. It is thought that by blocking the NMDA receptor and the effects of glutamate, memantine may protect nerve cells from excess stimulation by […]
A recent study suggests that a warning sign may come before any symptoms of Alzheimer’s disease: Adults who do not get enough deep sleep may be on their way to developing the disease. A lack of deep sleep may lead to Alzheimer’s disease. Researchers from the Washington University School of Medicine in St. Louis, MO, found that older people who experience less slow-wave sleep (in other words, deep sleep) have elevated levels of a brain protein called tau. The findings, published in Translational Medicine, note that higher levels of tau are a sign of Alzheimer’s disease. Elevated levels have also previously been associated with both brain damage and cognitive decline. Slow-wave sleep and brain proteins Slow-wave sleep helps people consolidate their memories and experiences, and getting enough of this type of sleep helps people wake up refreshed and energized. In order to find out if there is a connection between a lack of deep sleep and the development of Alzheimer’s, the authors put together a study that involved 119 people aged 60 years or older. A full 80 percent of the participants had no cognition problems, and the rest had only mild impairment. To conduct the study, researchers monitored their […]
The blood-brain barrier is a protective layer that surrounds the brain. Its main function is to prevent potentially harmful agents from leaking into this organ. However, it can also stop certain therapeutic drugs from reaching their target. Using ultrasound in new ways could open the door to better treatments for conditions that affect the brain. The blood-brain barrier prevents antitumor drugs and those that fight the symptoms of neurological conditions such as Alzheimer’s disease from reaching the brain and doing their work. Scientists can address this issue by temporarily bypassing the blood-brain barrier by using low-frequency ultrasound pulses. So far, they have only experimented with long-wave ultrasound pulses. However, these can bring on side effects, such as brain tissue damage and prolonged exposure to harmful molecules penetrating the blood-brain barrier alongside the drugs. Now, research conducted at Imperial College London in the United Kingdom suggests that a new approach to ultrasound disruption of the blood-brain barrier may work better and cause fewer problems. The team — led by James Choi, Ph.D. — is focusing on the use of shorter-wave ultrasound pulses, which the scientists have recently tested in mouse models. Following the new research, the results of which appear in […]
By Maureen SalamonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Dec. 12, 2018 (HealthDay News) — The toll of U.S. military service can be steep for female veterans, with depression, post-traumatic stress disorder and brain injury each significantly raising the odds of later dementia, new research suggests. The study, of more than 100,000 older women veterans, spotlights the risk factors stemming from military service that can lead to thinking and memory problems down the road, said study author Dr. Kristine Yaffe. “It’s really the first time anybody in the world has tried to understand women veterans and their risks for dementia,” said Yaffe, a professor of psychiatry, neurology and epidemiology at the University of California, San Francisco. “Nothing was known about these older women, yet more and more women are going into the military and more younger women are in combat,” she added. Yaffe is also a physician at the San Francisco VA Medical Center. She said her prior research showed similar effects in male veterans. “I thought we should try to understand more about older women veterans and … if some of the things we’ve shown in the past about men also relate to women,” she explained. Women accounted for more […]
Latest Alzheimer’s News FRIDAY, June 7, 2019 (HealthDay News) — People with Alzheimer’s disease who take opioid painkillers are more likely to develop pneumonia, Finnish researchers report. The overall odds are 30% higher, especially in the first two months of use, the researchers found. And the risk is highest for those taking strong opioids such as oxycodone or fentanyl. However, pneumonia risk also rose among Alzheimer’s patients who took milder opioids, according to the team from the University of Eastern Finland. Why might this be? Aleksi Hamina, a researcher in the university’s School of Pharmacy, and colleagues explained that opioids can impair the cough reflex, interfere with normal respiratory function, and cause sleepiness and fatigue. All of these factors could increase pneumonia risk, the study authors said. For their study, the investigators analyzed data collected in 2010 and 2011 from more than 5,600 Alzheimer’s patients in Finland. Patients who used opioids were matched with Alzheimer’s patients who were not prescribed the drugs. The findings were published recently in the Journal of Alzheimer’s Disease. It is often difficult to assess pain among Alzheimer’s patients due to problems with communication, the researchers explained in a university news release. So if opioid painkillers […]
An international working group of experts has agreed on guidelines to help increase scientific and public awareness about a brain condition that mimics Alzheimer’s disease. The condition is not new but has come to light in recent research and clinical trials. Researchers have identified a misfolded protein in the brain that may be ‘a possible Alzheimer’s mimic.’ Scientists have recently recognized Limbic-predominant Age-related TDP-43 Encephalopathy (LATE) as a “newly named pathway to dementia.” The working group consists of scientists from a number of centers that receive support from the National Institutes of Health (NIH), together with colleagues from other countries. The experts suggest that the public health impact of LATE on people in their mid-80s and older is probably about the same, if not bigger, than that of Alzheimer’s disease. In a report that now features in the journal Brain, the group proposes the first definition of LATE and recommends guidelines for those who are concerned with diagnosis and furthering research. Richard J. Hodes, M.D., who is director of the National Institute on Aging (NIA), which forms part of the NIH, says that even though researchers working on Alzheimer’s disease are making progress, they still ask themselves: “When is Alzheimer’s […]
A large study concludes that atrial fibrillation does, indeed, raise the risk of dementia even in people who did not have a stroke and that anticoagulants may reduce this risk. An irregular heartbeat may be a sign of A-fib, which may, in turn, raise dementia risk. Atrial fibrillation (A-fib) is a condition in which the heart beats irregularly. More specifically, the atria of the heart — the chambers that receive blood and pump it out to the heart’s ventricles and the rest of the body — beat at an irregular rhythm. A-fib is the most common form of arrhythmia, affecting between 2.7 and 6.1 million adults in the United States. Previous research has shown that people with A-fib have a higher risk of dementia, and also that people can take blood thinners to reduce this risk. New research confirms that the above is true, even in people who never experienced a stroke. The new study is the largest of its kind ever conducted. Boyoung Joung, who is a professor of cardiology and internal medicine at Yonsei University College of Medicine in Seoul, Republic of Korea, is the leading author of the paper, which appears in the European Heart Journal. A-fib […]
What is donepezil, and how does it work (mechanism of action)? Donepezil is an oral medication used to treat Alzheimer’s disease. It belongs to a class of drugs called cholinesterase inhibitors that also includes tacrine (Cognex). Scientists believe that Alzheimer’s disease may result from a deficiency in chemicals (neurotransmitters) used by nerves in the brain to communicate with one another. Donepezil inhibits acetylcholinesterase, an enzyme responsible for the destruction of one neurotransmitter, acetylcholine. This leads to increased concentrations of acetylcholine in the brain, and the increased concentrations are believed to be responsible for the improvement seen during treatment with donepezil. Donepezil improves the symptoms but does not slow the progression of Alzheimer’s disease. Donepezil was approved by the FDA in 1996. What brand names are available for donepezil? Aricept, Aricept ODT Is donepezil available as a generic drug? Yes Do I need a prescription for donepezil? Yes What are the uses for donepezil? Donepezil is used for the treatment of mild, moderate, or severe dementia associated with Alzheimer’s disease. What are the side effects of donepezil? The most common side effects associated with donepezil are: headache, generalized pain, fatigue, dizziness, nausea, vomiting, diarrhea, loss of appetite, weight loss, muscle cramping, […]
The herpes virus could account for at least half of Alzheimer’s cases, according to a new review of the findings of three recent studies examining links between Alzheimer’s and herpes. Infection with the herpes simplex virus may boost the likelihood of developing Alzheimer’s, researchers suggest. The new paper, published in the Frontiers in Ageing Neuroscience journal, also suggests that antiviral drugs may reduce the risk of senile dementia — which is mostly caused by Alzheimer’s disease — among people who have severe cases of herpes. Herpes simplex virus 1 (HSV1) is the type of herpes that results in cold sores. HSV1 is a common virus, and the majority of people will have contracted it by the time they reach old age. However, the virus remains permanently in the body and cannot be decisively removed either by the body’s natural defense mechanisms or by drugs. The virus is inactive most of the time, but when a person has HSV1, they may find that flare-ups occur when they are stressed or sick, resulting in characteristic blisters. Medical News Today have reported on several studies this year alone that have provided evidence of a connection between Alzheimer’s and herpes. In June, we looked […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Aug. 21, 2019 (HealthDay News) — Could a pacemaker for the brain improve the memories of people with dementia or Alzheimer’s disease? New research suggests it might be possible one day: Electrical stimulation directed at key memory regions of the brain created intense flashbacks in some Alzheimer’s patients, including sensations of emotions, smells, taste and temperature. In one case, a patient suddenly recalled “an entire experience of being inebriated while drinking a margarita at a resort in Aruba,” researchers said. In another, a man had a vivid flashback of feeling very full after eating sardines on his front porch two decades previously. In fact, about half of the 42 Alzheimer’s patients in the clinical trial experienced electrically induced flashbacks from decades prior, stretching back as far as the Vietnam War era, said lead researcher Dr. Wissam Deeb, an assistant professor of neurology at the University of Florida. “These memory recollections were very vivid for some people,” Deeb said. “They were associated with a lot of emotional content when patients remembered them, because they were memories they hadn’t even thought of for such a long time.” Researchers cautioned that the deep brain stimulation […]
A common class of drugs that doctors prescribe for a number of conditions — from bladder problems to Parkinson’s disease and depression — may increase a person’s risk of dementia, a large new study concludes. Some common drugs may increase dementia risk. New research by scientists from the University of Nottingham in the United Kingdom has analyzed the link between a certain class of drugs and the risk of dementia. The drugs in question, called anticholinergics, work by inhibiting a chemical messenger called acetylcholine. Their effect is to help relax or contract muscles, and doctors can prescribe them to help treat bladder conditions, gastrointestinal problems, and some of the symptoms of Parkinson’s disease. In their new study, which looked at data from tens of thousands of participants, the researchers concluded that anticholinergics may increase a person’s risk of developing dementia. The National Institute for Health Research funded this study, and the scientists published their findings yesterday in JAMA Internal Medicine. An almost 50% increase in risk For their study, lead researcher Prof. Carol Coupland and team analyzed the medical records of 58,769 people with dementia and 225,574 people without dementia. They were all 55 years old or above at baseline. […]
Extreme daytime sleepiness is often a top symptom of Alzheimer’s disease but what, exactly, causes it? New research finally brings us an answer. A specific type of protein may cause daytime sleepiness in people with Alzheimer’s, according to a recent study. Many people with Alzheimer’s disease have a tendency to sleep a lot during the day, even when they have had a full night’s sleep. Based on links between excessive sleepiness and neurodegenerative conditions, researchers are speculating that looking at daytime napping patterns could help predict the development of Alzheimer’s. But what remains unclear is why, exactly, people with this condition experience the need to sleep so often. A new study, conducted by researchers at the University of California, San Francisco (UCSF) and other institutions, shows that people with Alzheimer’s disease experience major brain cell loss in regions of the brain tasked with keeping us awake. The findings, which appear in the journal Alzheimer’s & Dementia, also suggest that an overaccumulation of tau protein triggers these brain changes. In Alzheimer’s disease, tau proteins form tangles that disrupt communication between neurons (brain cells) and impact cell health. “Our work shows definitive evidence that the brain areas promoting wakefulness degenerate due to […]
It is natural for a person’s memory and thinking abilities, or cognitive function, to wane as they age — even if they are in good health. However, the rate of cognitive decline can speed up if they experience heart attack or angina, according to new research. Cognitive decline may speed up after a heart attack or angina. Studies that have explored the links between circulation problems and cognitive decline have tended to focus on conditions that affect the blood supply to the brain, such as stroke. Few of these earlier studies, however, have looked at the long-term links between incident coronary heart disease (CHD), such as heart attack and angina, and cognitive decline. The recent Journal of the American College of Cardiology study is unique; it tracked cognitive decline both before and after incident CHD. “Incident CHD,” its authors conclude, “is associated with accelerated cognitive decline after, but not before, the event.” They suggest that the findings highlight the long-term relationship between cognitive decline and CHD. Lead and corresponding study author Wuxiang Xie, Ph.D., says that because there is not yet a cure for dementia, it is important to detect and treat the brain condition as early as possible in […]
Alzheimer’s disease is a form of neurocognitive decline that affects millions across the world. The exact cause is unclear, but new research is uncovering the mechanisms that allow Alzheimer’s to become established in the brain. Which brain cells are the most vulnerable to Alzheimer’s? In Alzheimer’s disease, as in other forms of dementia, a defining feature is the accumulation of certain toxic proteins in the brain. These proteins aggregate into plaques that disrupt the communication between brain cells, thus enhancing cognitive problems and other issues. More often than not, researchers identify the protein beta-amyloid as the main culprit in this disruptive process. However, another protein, called tau, is just as important. In a new study, researchers from a series of academic institutions, including the Ohio State University in Columbus, Columbia University Medical Center in New York, NY, and Cambridge University in the United Kingdom, have found that tau accumulates preferentially around a specific type of brain cell. The investigators also revealed that certain genetic profiles may predispose a person to tau aggregations around those cells. Co-lead author of the study Hongjun (Harry) Fu — now an assistant professor in the Department of Neuroscience at Ohio State University — and colleagues […]
Latest Alzheimer’s News THURSDAY, Aug. 8, 2019 (HealthDay News) — Want to reduce your risk of dementia? Take care of your heart. That’s the takeaway from a new study that suggests good heart health in middle age could lower your odds for problems with thinking and memory later in life. The study included nearly 7,900 British adults who did not have heart disease or dementia at age 50. Over an average 25-year followup, 347 cases of dementia were diagnosed among participants. Average age at diagnosis: 75. After taking other factors into account, researchers linked a higher score at age 50 on seven healthy habits outlined in the American Heart Association’s “Life Simple 7” with a lower risk of dementia later in life. The Life Simple 7 assesses smoking, diet, physical activity, fasting blood sugar, blood cholesterol, blood pressure and body mass index (a measure of body fat based on height and weight). Dementia rates were 1.3 per 1,000 person years among participants who had high scores on heart healthy habits, compared to 3.2 per 1,000 for low-scorers, according to the study published Aug. 7 in the BMJ. A better score at age 50 was also associated with higher overall brain […]
New research in the Journal of Biological Chemistry breaks down the process through which tau tangles grow as long as they do. The findings may lead to new therapies that target the formation of tau aggregates in Alzheimer’s disease. Researchers knew that Alzheimer’s-related tau aggregates consisted of a small number of long tau fibrils. One of the hallmarks of Alzheimer’s disease is the so-called tau tangles. Tau is a protein contained within the axons of the nerve cells. More specifically, tau helps form microtubules — essential structures that transport nutrients within nerve cells. In a healthy brain, the tau protein helps these microtubules remain straight and strong. But in Alzheimer’s, tau collapses into aggregates called tangles. When this happens, the microtubules can no longer sustain the transport of nutrients and other essential substances in the nerve cells, which eventually leads to cell death. How toxic and damaging these tau tangles can be, and how far they can spread, depends on their length. However, until now, scientists did not know why some tau tangles are longer than others in Alzheimer’s, or how these aggregates grow so long in the first place. But now, scientists at the Ohio State University in Columbus […]
Latest Alzheimer’s News MONDAY, June 24, 2019 (HealthDay News) — Doctors often prescribe anticholinergic drugs for a variety of ills. But a new study suggests they may increase the risk of dementia in older patients. These medicines include everything from Benadryl (diphenhydramine) to certain antipsychotics and Parkinson’s meds. They’re used to treat a wide range of other conditions, including depression, chronic obstructive pulmonary disease, overactive bladder, allergies, and gastrointestinal disorders. Anticholinergic drugs help contract and relax muscles, and work by blocking acetylcholine, a chemical that transmits messages in the nervous system. But the new British study found that people aged 55 and older who took strong anticholinergic medications daily for three years or more had a 50% increased risk of dementia. “Our study adds further evidence of the potential risks associated with strong anticholinergic drugs, particularly antidepressants, bladder antimuscarinic drugs, anti-Parkinson drugs and epilepsy drugs,” said study author Carol Coupland. She works in the division of primary care at the University of Nottingham. Anticholinergics are known to cause short-term side effects — including confusion and memory loss — but it’s unclear if long-term use increases the risk of dementia. To find out, Coupland’s team examined the medical records of nearly […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, July 17, 2019 (HealthDay News) — Even if you are at high risk for Alzheimer’s disease, a little more exercise may buy you time, new research suggests. Folks with elevated levels of a brain protein called beta amyloid tend to be more likely to develop Alzheimer’s disease and experience rapid brain decline later in life, previous research has found. But apparently they can delay the onset of Alzheimer’s through regular exercise, scientists report. “People who had elevated levels of amyloid, which is one of the earliest changes you see with Alzheimer’s disease, had slower rates of cognitive decline and brain volume loss over time if they had greater levels of physical activity,” said lead researcher Jennifer Rabin. She is a scientist with the Hurvitz Brain Sciences Program at the Sunnybrook Research Institute in Toronto. It didn’t take much exercise to enjoy this protection, either. The data suggests that people who walked 8,300 to 8,900 steps per day significantly delayed the onset of Alzheimer’s, Rabin said. Previous studies have shown that older people who exercise generally tend to stay sharp longer into old age, but this new research shows physical activity is specifically […]
A new study investigates the effect of leading a healthful lifestyle on people who have a genetic predisposition to developing dementia. Leading a healthful lifestyle can offset the genetic risk of dementia, according to a new study. Elżbieta Kuźma, Ph.D., and David Llewellyn, Ph.D., from the University of Exeter Medical School in the United Kingdom, are the joint lead authors of the new research, which appears in the journal JAMA. Llewellyn, Kuźma, and colleagues also presented their findings at the Alzheimer’s Association International Conference 2019, which took place in Los Angeles, CA. In their paper, the authors explain that while scientists know that genes and lifestyle both significantly affect Alzheimer’s risk and the likelihood of other types of dementia, they do not yet know the extent to which making healthful lifestyle choices can offset the genetic risk. For instance, research has shown that the E4 variant of the gene that encodes the apolipoprotein E raises the risk by threefold if a person inherits one copy and up to 15 times if they have two copies of the gene. However, a significant body of research also points to the fact that people who do not smoke, are physically active, only consume […]
According to a team of Swedish-based researchers, breathing through the nose may help memory storage and consolidation. These findings are published in The Journal of Neuroscience. The way we breathe affects our memory in mysterious ways. Recently, neuroscientists have been scrutinizing the link between smell and memory. Some have suggested that a damaged sense of smell can predict dementia, and others have zoomed in on why that may be. Along the way to unraveling the Proustian mysteries of smells and memory, scientists have picked up several clues. The amygdala, which is a small brain region that processes sensory information, is close to the memory-storing hippocampus. Also, newer research shows that people with a good spatial memory may be better at identifying smells. Information related to time and space is present in the anterior olfactory nucleus, studies have shown. This is a brain area that is involved in the development of Alzheimer’s. New research now adds breathing into the mix. A study carried out by scientists at the Karolinska Institutet in Stockholm, Sweden, finds that breathing through the nose, rather than the mouth, improves olfactory memory. Artin Arshamian, a researcher at the Department of Clinical Neuroscience with the Karolinska Institutet, is […]
Latest Alzheimer’s News FRIDAY, May 10, 2019 (HealthDay News) — Cuddler the bear, Aibo the dog, Justocat the purring kitty: They may only be furry, lifelike robots, but they have a made a real impact in nursing homes. That’s the finding of new British research that suggests these high-tech “robopets” are the next best thing for nursing home residents unable to have a beloved pet or those suffering from loneliness. “Although not every … resident may choose to interact with robopets, for those who do, they appear to offer many benefits,” study author Rebecca Abbott, of the University of Exeter Medical School, said in a university news release. The robopets stimulate conversations and trigger fond memories of pets or past experiences, Abbott said. “And there is also the comfort of touching or interacting with the robopet itself. The joy of having something to care for was a strong finding across many of the studies.” One U.S. geriatrician who was not involved in the study said engagement with a robotpet does seem helpful. “Most importantly, it was found to decrease loneliness and increase pleasure and joy, and bring comfort,” said Dr. Maria Torroella Carney. She directs geriatrics and palliative medicine at […]
Recent research into older adults confirms that loneliness is tied to a raised risk of developing dementia. The study also reveals that the effect ranges across a diversity of people and is independent of how much social contact they have. A large new study confirms that loneliness is a risk factor for dementia. Scientists from Florida State University (FSU) in Tallahassee used data on 12,030 individuals from the Health and Retirement Study, a United States government-sponsored longitudinal survey of a nationally representative sample of people aged 50 and older. They report their findings in a paper that now features in The Journals of Gerontology: Series B. “We are not the first people,” says first study author Dr. Angelina Sutin, who is an associate professor in FSU’s College of Medicine, “to show that loneliness is associated with increased risk of dementia.” “But this is by far the largest sample yet, with a long follow-up,” she adds. “And the population was more diverse.” The study data contained measures of loneliness and social isolation and a range of risk factors, including behavioral, clinical, and genetic. Through telephone interviews, individuals had also completed assessments of cognitive ability, a low score on which indicates dementia. […]
New research, published in the journal Nature Genetics, identifies new genetic risk factors for Alzheimer’s disease. It also uncovers novel biological mechanisms that may lead to this neurodegenerative condition. Scientists have found new genetic locations associated with Alzheimer’s. About 5.7 million people in the United States are currently living with Alzheimer’s disease. A recent report issued by the Centers for Disease Control and Prevention (CDC) predicts that by the year 2060, this number will grow to 13.9 million. Genes play an important role in whether a person will develop Alzheimer’s or not. Researchers estimate that 60–80 percent of the disease is heritable. Therefore, identifying the genes that put some people at risk of Alzheimer’s is an important scientific endeavor. So far, studies have found more than 20 genetic locations that have links with the condition, but these only explain a small percentage of the genetic variance that accounts for Alzheimer’s. So, a team of scientists has set out to uncover more genetic risk factors. Professor Danielle Posthuma, from the Vrije Universiteit University in Amsterdam, Netherlands, together with Dr. Ole Andreassen from the University of Oslo, Norway, and Dr. Stephan Ripke from the Broad Institute in Boston, MA, led the new […]
Dementia and Alzheimer’s disease are similar but not the same. Dementia is a general term and has many different types, of which Alzheimer’s is one. There is sometimes confusion between the two because people often use the terms interchangeably. Dementia is an umbrella term used to describe a set of symptoms that broadly affect cognitive functioning, including: memory thinking and focus problem solving language visual perception Alzheimer’s disease is a specific type of dementia that causes a gradual decline in memory and thinking. What is dementia? Some dementia symptoms can be mild and difficult to detect. Dementia is a syndrome, which means that it describes a collection of symptoms with no specific cause. A syndrome is different from a disease, which has specific symptoms and a common cause. Dementia can affect a wide range of mental functions. As a result, many different diseases and conditions are types of dementia. Alzheimer’s disease is the most common form of dementia, but there are several other types, including: vascular dementia, which results from strokes or other conditions that block blood flow to the brain Lewy body dementia, which is a result of abnormal protein deposits in the brain frontotemporal disorders, which are types […]
There is no doubt that smoking damages health and increases the risk of many diseases and premature death. However, a study that followed hundreds of older adults for more than 10 years found no link between tobacco smoking and raised dementia risk. A new study suggests there is no causal link between smoking and the risk of developing dementia. Dementia is the general name for conditions that diminish the capacity to think, remember, reason, and interact with others. These symptoms can progress to the point that people are no longer able to carry out their daily activities and take care of themselves. The recent finding contradicts many earlier studies that have tied smoking to higher risk of dementia. This could be because, for the new investigation, researchers from the University of Kentucky in Lexington analyzed the data in a different way. They used a statistical method called “competing risk analysis” to allow for the strong effect that smoking has on risk of death. In a paper that now features in the Journal of Alzheimer’s Disease, first study author Erin L. Abner Ph.D., an associate professor in the university’s Sanders-Brown Center on Aging, and her colleagues describe their approach and findings. […]
A number of warning/advisory letters have been issued to 17 companies for selling illegal products that claim to prevent, treat or cure Alzheimer’s disease and other serious conditions, the U.S. Food and Drug Administration says. Latest Alzheimer’s News The agency said it posted 12 warning letters and five online advisory letters to U.S. and foreign companies illegally selling more than 58 products, many of which are marketed as dietary supplements. The products — which include tablets, capsules and oils and are often sold on websites and social media — have not been reviewed by the FDA and may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment, according to the FDA The companies have 15 days to respond to the FDA and outline how they intend to correct the violations. Product seizures and/or injunctions are among the actions the FDA could take if the violations are not corrected. “Science and evidence are the cornerstone of the FDA’s review process and are imperative to demonstrating medical benefit, especially when a product is marketed to treat serious and complex diseases like Alzheimer’s,” FDA Commissioner Dr. Scott Gottlieb said in an agency news release. “Alzheimer’s is a […]
Latest Alzheimer’s News TUESDAY, April 2, 2019 (HealthDay News) — Brain scans can improve diagnosis and management of Alzheimer’s disease, a new study claims. Researchers assessed the use of PET scans to identify Alzheimer’s-related amyloid plaques in the brain. The study included more than 11,000 Medicare beneficiaries with mild thinking impairment or dementia of uncertain cause. This scanning technique changed the diagnosis of the cause of mental impairment in more than one-third of the participants in the study. The brain scan results also changed management — including the use of medications and counseling — in nearly two-thirds of cases, according to the study published April 2 in the Journal of the American Medical Association. “These results present highly credible, large-scale evidence that amyloid PET imaging can be a powerful tool to improve the accuracy of Alzheimer’s diagnosis and lead to better medical management, especially in difficult-to-diagnose cases,” said study co-author Maria Carrillo, chief science officer of the Alzheimer’s Association. “It is important that amyloid PET imaging be more broadly accessible to those who need it,” she added in an association news release. Funding for the study came from Avid Radiopharmaceuticals Inc., General Electric Healthcare, and Life Molecular Imaging. “We are […]
Recent research suggests that doing even low-intensity physical activity allows older people to reduce their risk of dementia. Carrying out even basic activities in older age might help maintain brain health. Several factors can affect a person’s chance of developing dementia. Some of the factors, such as age and genetics, are unavoidable. Others, such as smoking and other unhealthful behaviors, are lifestyle choices that a person can change. Regularly exercising and eating a healthful diet may prevent the onset of symptoms, say the Alzheimer’s Association. However, a new study that appears in the journal Neurology has revealed that any kind of physical activity — including basic tasks such as doing housework — may protect a person’s brain when they have already reached old age. The researchers — from Rush University Medical Center in Chicago, IL — studied 454 older adults. Of these, 191 had a diagnosis of dementia. Every participant agreed to donate their brain for medical research purposes when they died. Every year for 2 decades, each person underwent a full physical examination, along with a test, to determine their thinking and memory skills. The scientists gave all the volunteers an activity-monitoring device called an accelerometer around 2 years […]
For years, many experts have assumed that spending more time in education protects against dementia. The latest study may overturn this long-held theory. A new study examines the links between education and dementia risk over time. It will have escaped no one’s attention that dementia is on the rise. The most common type of dementia is Alzheimer’s. According to the Alzheimer’s Association, an estimated 5.7 million adults in the United States have Alzheimer’s. Primarily due to our increasing lifespan, dementia incidence is set to keep rising. Currently, there is no cure, and treatments can only reduce certain symptoms. For this reason, it is vital that we understand the relevant risk factors and discover ways to prevent or slow down dementia. Some risk factors are well-known, such as smoking and lack of physical activity. Well-known protective factors include sticking to a healthful diet. Education and cognitive reserve Many experts think that the length of time someone spends in education helps protect against dementia. Although studies have generated conflicting or inconclusive results, many researchers believe that higher levels of educational attainment provide an individual with a certain “cognitive reserve.” Scientists believe that this hypothetical reserve lowers the risk or, at the very […]
Recent research suggests that a maternal diet that is high in an essential nutrient can reduce the impact of Alzheimer’s disease on future generations. Meat, fish, eggs, and dairy are the main dietary sources of choline. In the study, scientists bred mice that were genetically predisposed to develop hallmarks of Alzheimer’s disease from females whose diet contained added choline. The descendants of these females developed fewer disease-associated brain changes and had improved memory skills compared with those of non-supplemented mice. The researchers, who are from Arizona State University (ASU) in Tempe and the Translational Genomics Research Institute in Phoenix, AZ, bred two generations of mice from the choline-supplemented females. They found that the protective effect of “maternal choline supplementation” persisted across multiple generations, even though the descendants’ diets were not enriched with choline. The journal Molecular Psychiatry has now published a paper on the study. Choline: An essential nutrient Choline is an essential nutrient that the body needs for many functions, including early brain development and the preservation of cell structure. While the human body can make some of the choline that it needs, it has to obtain the rest from dietary sources. In the United States, animal products such […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, July 17, 2019 (HealthDay News) — One of the hallmarks of Alzheimer’s is the accumulation of beta-amyloid plaques in the brain, but what part those plaques play in the development of the disease isn’t clear. Now researchers have taken the first steps to trace the progression of plaque buildup in living patients. This way of “staging” the disease has implications for research and one day may help doctors treat this debilitating, fatal disease. “It is possible to stage individuals in terms of how advanced their beta-amyloid deposition is, using PET scans,” said lead researcher Dr. Niklas Mattsson, an associate professor of clinical neuroscience at Lund University in Sweden. When beta-amyloid appears, it follows certain stages, he explained. Some brain regions are involved early, others at the intermediate stage, and some in the late stage of Alzheimer’s. “These stages are also associated with other hallmarks of Alzheimer’s disease, such as levels of tau [another type of protein] in cerebral spinal fluid, cognitive decline and the wasting away of brain cells,” Mattsson added. “This staging system can be used both to improve research and perhaps also in clinical trials, to see if certain drugs […]
(HealthDay News) — If you are caring for a loved one who has Alzheimer’s disease, you may develop feelings of grief as the person starts to change, the Alzheimer’s Foundation says. Latest Alzheimer’s News There are five phases of grieving: denial, anger, guilt, sadness and acceptance. The association suggests how to cope with grief and loss: Face your feelings and accept them. Prepare to have feelings of loss as dementia progresses. Understand that no two people grieve in exactly the same way. Talk with someone you trust about your feelings. Stay involved in activities that you enjoy. Join a support group. Accept things that you cannot change. Take care of yourself. Copyright © 2018 HealthDay. All rights reserved. CONTINUE SCROLLING FOR NEXT NEWS ARTICLE
Researchers reveal a marker and new testing tool of frontotemporal dementia that may help distinguish this condition from Alzheimer’s disease. ‘Moral emotions’ are ones that prompt us to do good and contribute to pro-social behavior and cooperation. Frontotemporal dementia (FTD) is a less common form of dementia than Alzheimer’s. Sometimes called Pick’s disease or frontal lobe dementia, this condition occurs when brain cells in the frontal or temporal lobes of the brain, or both, become damaged. The frontal lobes of a person’s brain are responsible for problem-solving, planning, emotional control, and behavior. FTD may also affect the temporal lobes, which can be found on each side of the brain and deal with speech, the meaning of words, and recognition of faces or objects. In addition to difficulties with language, FTD also causes changes in personality and behavior. For instance, people with FTD may experience mood changes that do not normally characterize them. They may act more impulsively, lose their social inhibitions, feel apathetic, or lose interest in the emotions of other people or in socializing. Although some of these symptoms are similar to other, more common forms of dementia, such as Alzheimer’s disease, FTD is different from Alzheimer’s. In an […]
Research has linked a particular sleep disorder called rapid eye movement (REM) sleep behavior disorder with a diagnosis of Parkinson’s disease. What characterizes this sleep problem, and can its presence be a good way to predict Parkinson’s risk? People who experience a sleep disorder that causes them to act out their dreams have a high risk of developing Parkinson’s disease. Data from the National Institutes of Health (NIH) indicate that every year, approximately 50,000 people in the United States learn that they have Parkinson’s disease, a neurological condition that affects a person’s motor function and exposes them to other neurodegenerative problems, such as Alzheimer’s disease. Researchers still do not fully understand exactly what causes Parkinson’s disease, but they have identified a few risk factors that can predispose a person to develop this condition. These include a person’s age and sex as well as some genetic factors. Still, it remains a challenge to establish early on who is likely to develop Parkinson’s disease at some point in their life. However, a team of researchers from McGill University in Montreal, Canada decided to see if one particular factor — a sleep disorder called REM sleep behavior disorder (RBD) — could be a […]
It is still unclear exactly what causes Alzheimer’s disease, which is a neurodegenerative condition chiefly characterized by memory loss and other forms of cognitive impairment. However, new research is uncovering more of the factors that contribute to its pathology. According to a new study, a blood protein leaked into the brain contributes to cognitive decline. According to existing guidelines, the main mechanism associated with cognitive problems in the brains of people with Alzheimer’s disease is the formation of beta-amyloid plaques. These are buildups of toxic proteins that disrupt the normal functioning of synapses. Synapses are the connections formed between brain cells that allow information to circulate within and to and from the brain. However, in a new study from the Gladstone Institutes in San Francisco, CA, a team of researchers has identified another mechanism that affects how synapses work, contributing to Alzheimer’s pathology. The researchers began by investigating problems that appear in the blood vessel network in the brain, which is another biological characteristic of this form of dementia. Senior investigator Prof. Katerina Akassoglou and her team have for the first time identified a blood-derived protein that leaks into the brain disrupting cell-to-cell communication. The findings, which appear in the […]
Researchers have previously shown that a type of light therapy could potentially reduce toxic proteins that build up in the brain in Alzheimer’s disease. Now, the same team has identified what happens at cell level to achieve this result. A recent study asked why flickering light might help fight Alzheimer’s. In 2016, scientists at Massachusetts Institute of Technology (MIT) in Cambridge found that shining a flickering light into the eyes of mice could reduce the toxic buildup of amyloid and tau proteins that occur in the brain with Alzheimer’s disease. Light therapy boosts a form of brain wave called gamma oscillation, which research suggests is impaired in people with Alzheimer’s disease. More recently, the MIT team revealed that combining light therapy with sound therapy extended the beneficial effects even further. Those studies also saw that light therapy can improve memory in mice genetically predisposed to develop Alzheimer’s disease and spatial memory in older mice without the condition. The most recent investigation, which now features in the journal Neuron, has shown that boosting gamma oscillations can improve the connection between nerve cells, reduce inflammation, and preserve against cell death in mouse models of Alzheimer’s. It also shows that the treatment’s far-reaching […]
A recent study has concluded that people with both higher-than-normal and lower-than-normal levels of hemoglobin have a higher risk of developing dementia as they age. A new paper looks at the link between hemoglobin and dementia risk. Hemoglobin is a protein present in red blood cells. It is responsible for carrying life giving oxygen from the lungs to the rest of the body. Low levels of hemoglobin normally signify anemia. Anemia is one of the most common blood disorders; worldwide, it affects an estimated 1.62 billion people. Low hemoglobin levels are linked to a number of adverse health outcomes, including stroke and coronary heart disease. However, there is little information regarding how hemoglobin levels might relate to the risk of dementia. Anemia and dementia Recently, researchers from the Erasmus Medical Center in Rotterdam, the Netherlands, decided to look for links between hemoglobin levels, anemia, and dementia. They published their findings this week in the journal Neurology. Earlier experiments had found an association between anemia and dementia, but most studies only followed participants for an average of 3 years. Because of the relatively short duration of these investigations, subtle changes in behavior, diet, or metabolism during the early phases of dementia […]
Latest Alzheimer’s News WEDNESDAY, Sept. 11, 2019 (HealthDay News) — Sleep loss is a problem for people who care for loved ones with dementia, which can put both caregivers and patients at risk, researchers say. Investigators at Baylor University in Waco, Texas, found caregivers lost between 2.5 to 3.5 hours of sleep a week due to difficulty falling asleep and staying asleep. “Losing 3.5 hours of sleep per week does not seem much, but caregivers often experience accumulation of sleep loss over years,” said review lead author Chenlu Gao, a doctoral candidate of psychology and neuroscience. “Losing 3.5 hours of sleep weekly on top of all the stress, grief and sadness can have a really strong impact on caregivers’ cognition, and mental and physical health,” Gao added in a university news release. But improving caregivers’ sleep quality can significantly improve their functioning and quality of life, Gao said. For example, the researchers found that caregivers’ sleep noticeably improved after simple changes such as getting more morning sunlight, establishing a regular and relaxing bedtime routine, and doing moderate physical exercise. Chronic stress can cause sleep problems, and nighttime awakenings by people with dementia can also disrupt caregivers’ sleep, the researchers noted. […]
(HealthDay News) — Mild memory issues are common from time to time, especially as you age, the U.S. Food and Drug Administration says. Latest Alzheimer’s News The agency says anything that affects the processes of thinking and learning can affect memory. It mentions these common causes of memory loss: Certain drugs can interfere with memory, including over-the-counter and prescription sleeping pills, antihistamines, anti-anxiety medications, antidepressants, schizophrenia medications and pain medicines. Heavy alcohol use can cause a deficiency in vitamin B1, which can affect memory. Stress, particularly because of emotional trauma, can trigger memory loss. Depression may trigger a lack of attention and focus that can affect memory. A blow to the head can trigger memory loss. People with HIV, tuberculosis, syphilis, herpes and other infections affecting the brain may have memory problems. An underactive or overactive thyroid can impact memory. Lack of quality sleep can affect memory. Deficiencies of vitamins B1 or B12 can affect memory. Copyright © 2018 HealthDay. All rights reserved.
A new drug for treating Alzheimer’s disease has successfully passed the first phase of testing in humans. Preclinical studies had already shown that the drug could improve memory and other symptoms of Alzheimer’s disease in older mice. A potential treatment for Alzheimer’s moves a step closer. Researchers at Forschungszentrum Jülich and Heinrich Heine University Düsseldorf, both in Germany, developed the candidate drug, which, for now, bears the name PRI-002. PRI-002 eliminates toxic beta-amyloid oligomers, the self-replicating proteins that scientists suspect of causing and advancing Alzheimer’s disease. The team had previously shown that the drug could significantly reduce signs and symptoms in older mice that were genetically engineered to develop an Alzheimer’s-like disease through the insertion of a mutant human gene. That preclinical study featured online in 2018 in the journal Molecular Neurobiology. In the ensuing, recently completed phase 1 clinical trial, healthy volunteers took daily dosages of PRI-002 for 4 weeks. The results show that the drug is safe for human use. Passing this stage of testing in humans means that the candidate drug can now proceed to a phase 2 trial to evaluate its effectiveness in people with Alzheimer’s disease. “Our next goal is the proof of efficacy in […]
New research examines the associations between migraine and Alzheimer’s disease, as well as related forms of dementia. The study finds that migraine is “a significant risk factor” for Alzheimer’s and all‐cause dementia. Could a history of migraine increase dementia risk? New research suggests so. According to the American Migraine Association, about 36 million people of all ages in the United States regularly experience migraine. That is about 12% of the population. Alzheimer’s disease and related forms of dementia were affecting 5 million U.S. adults in 2014, according to official estimates, and the figures are only expected to increase. While dementia is the most prevalent neurological condition in older adults, headaches are the most prevalent neurological condition across all ages, and migraine headaches are the most severe form. So, new research set out to investigate whether migraine is a risk factor for dementia. Identifying what raises the risk of dementia may enable more timely treatment interventions. Detecting dementia early on and starting treatment as soon as possible can improve the effectiveness of therapies and empower people with the condition and their families to make the right decisions at the right time. Suzanne L. Tyas, Ph.D., of the University of Waterloo, in […]
By the time that the symptoms of dementia emerge in Alzheimer’s disease, tissue damage is well underway in the brain. Now, scientists propose that specific psychiatric symptoms – such as depression, anxiety, sleep disruption, and loss of appetite – may serve as markers of very early brain changes in Alzheimer’s. Depression and anxiety may be signs of early-stage Alzheimer’s. Working with the Brazilian Biobank for Aging Studies (BBAS) at the University of São Paulo, investigators at the University of California in San Francisco (UCSF) studied results of postmortem brain tissue tests and compared them with psychiatric symptoms obtained from detailed interviews conducted with people who knew the deceased well, such as relatives and carers. They suggest that their study — a paper on which now features in the Journal of Alzheimer’s Disease — reveals that psychiatric symptoms are not the cause of Alzheimer’s, but more likely early indicators of the disease. Such markers could help doctors to diagnose Alzheimer’s disease much earlier and thus increase opportunities for slowing its progress, they note. Better understanding of Alzheimer’s The authors also propose that the findings could alter our understanding of how the biology of Alzheimer’s leads to psychiatric symptoms in people who […]
By Deborah DiSesa HirschHealthDay Reporter Latest Alzheimer’s News TUESDAY, Oct. 29, 2019 (HealthDay News) — Unpaid bills, overdrawn accounts, dwindling investments: When seniors begin experiencing fiscal troubles, early dementia or Alzheimer’s disease could be an underlying cause, researchers say. In the early stages of the disease, people with undiagnosed Alzheimer’s are at high risk of making foolish and dangerous decisions about their finances, mostly because families may not know they need help, researchers say. “Individuals often aren’t diagnosed early enough, and it’s a perfect storm,” said study author Carole Gresenz, a professor of health systems administration at Georgetown University in Washington, D.C. “They’re vulnerable to large reductions in liquid assets because they’re not making wise decisions about their finances, savings and checking accounts. This can also reduce net wealth,” added Gresenz. Ruth Drew, director of information and support services for the Alzheimer’s Association, pointed out that Alzheimer’s destroys the brain. “As the disease progresses, everyone with Alzheimer’s will reach a point where they need help with their finances and ultimately assistance with daily tasks and around-the-clock care. We have certainly spoken to people whose finances were significantly affected,” she said. In some cases, people responsible for making major financial decisions, […]
In a new study, researchers have found that a bacterium largely responsible for gum disease also contributes to the development of Alzheimer’s disease. A bacterium involved in gum disease boosts Alzheimer’s toxicity. According to data from the National Institute of Dental and Craniofacial Research, 8.52 percent of adults between 20 and 64 years of age in the United States have periodontitis (gum disease). Gum disease is a widespread problem that can lead to more negative outcomes, from tooth loss to an increased risk of cancer. Now, emerging evidence suggests that one of the bacteria involved in periodontitis could also contribute to the accumulation of toxic proteins in the brain, which scientists have associated with the development of Alzheimer’s disease. These findings have emerged from a new study in mice that researchers from Cortexyme, Inc., a pharmaceutical company that aims to develop new therapeutics for Alzheimer’s disease, have conducted. The results of the research — whose lead author is Dr. Stephen Dominy, Cortexyme co-founder — appear in the journal Science Advances. “Infectious agents have been implicated in the development and progression of Alzheimer’s disease before, but the evidence of causation hasn’t been convincing,” notes Dr. Dominy. The bacterium that boosts brain […]
Latest Alzheimer’s News WEDNESDAY, Oct. 23, 2019 (HealthDay News) — A diet high in trans fats could put you at increased risk for dementia, a new study suggests. Most trans fats were banned in the United States last year. But foods with less than a half-gram of trans fats can be labeled as containing zero, so some foods still contain them. The new study included over 1,600 people in Japan without dementia. Their average age was 70, and they were followed for an average of 10 years. During that time, 377 of them developed dementia. Of the 407 who started the study with the highest levels of trans fats in their blood, 104 developed dementia, a rate of 29.8 per 1,000 person-years. (A “person-year” is a formula that accounts for the number of people in a study and how long they were followed.) Among those with the second-highest level of trans fats, the rate was 27.6 per 1,000 person-years. The rate was 21.3 among those with the lowest trans fat levels in their blood. After adjusting for other dementia risk factors — such as high blood pressure, diabetes and smoking — the researchers concluded that compared to study participants with […]
Latest Alzheimer’s News By Dennis ThompsonHealthDay Reporter WEDNESDAY, Jan. 8, 2020 (HealthDay News) — Poor sleep has been linked to the development of dementia and Alzheimer’s disease, and now a new study suggests a possible reason why. A small group of young, healthy men deprived of just one night of sleep had higher blood levels of tau protein than when they had a full and uninterrupted night of rest, researchers reported in a study published online Jan. 8 in Neurology. “This is interesting as accumulation of the protein tau is seen in the brains of individuals afflicted by Alzheimer’s disease, or most common forms of dementia,” said senior study author Dr. Jonathan Cedernaes, a senior researcher at Uppsala University in Sweden. The researchers did not find any similar increase in amyloid beta, another brain protein long linked to Alzheimer’s, the Swedish researchers said. The new findings come as Alzheimer’s research has started to shift its focus towards tau as a more important cause of brain damage associated with the disease. Another group of researchers recently reported in the journal Science Translational Medicine that they can predict with reasonable accuracy which brain regions will wither and atrophy in Alzheimer’s by identifying […]
The symptoms of frontotemporal, or early onset, dementia can appear as early as age 40. Have researchers found a new way to treat this condition using antibiotics? Frontotemporal dementia, or frontotemporal lobar dementia, is an umbrella term that refers to a range of early onset dementias characterized by the progressive atrophying of the brain’s frontal lobes, temporal lobes, or both. The main symptoms in this form of dementia are cognitive function impairments and personality and behavioral changes. These can appear as early as age 40. Researchers explain that frontotemporal dementia is usually heritable, and they tie most cases to specific DNA mutations. Now, scientists at the University of Kentucky’s College of Medicine in Lexington — in collaboration with colleagues from other research institutions — have studied the mutated genes associated with frontotemporal dementia. They wanted to determine whether or not anything can prevent these genes from triggering the condition. In their new study, the findings of which appear in the journal Human Molecular Genetics, the researchers focused on one specific gene mutation. Fighting a key mutation with antibiotics? The study authors explain that, among others, a key player in this form of early onset dementia is a mutation in the […]
The buildup of defective tau proteins is a prominent feature of neurodegenerative diseases such as Alzheimer’s. The faulty proteins form tangles that disrupt brain function and kill nerve cells, or neurons. Experiments in human cell cultures reveal a mechanism through which scientists can regulate defective tau protein levels. Now, scientists have identified a molecule that plays a vital role in helping to prevent the buildup of toxic tau protein in the brain. The molecule, which has the name vacuolar protein sorting 35 (VPS35), identifies and removes faulty tau proteins from neurons. Using human cells, researchers from Lewis Katz School of Medicine (LKSOM) at Temple University in Philadelphia, PA, showed that they could control tau buildup by altering levels of VPS35. They describe the findings in a Molecular Psychiatry study paper. “A major part of what VPS35 does,” says senior study author Prof. Domenico Praticò, director of LKSOM’s Alzheimer’s Center at Temple, “is to sort out and transport dysfunctional proteins to degradation sites.” The researcher and his colleagues also found that VPS35’s effect on tau depends on the activity of cathepsin D, an enzyme that breaks down proteins in cells. Neurons vulnerable to defective proteins The correct folding of proteins is […]
close
The information contained within this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Members contribute personal experiences by sharing what did or didn’t work to address their concern and help educate others which may expedite recovery. As such, always seek the advice of your physician or other qualified health provider with any questions about your medical condition. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
Recent Comments